Come up with a name for your new list and we'll add to it:
Apse raised a round of funding on December 05, 2016. Investors include
National Science Foundation.
Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials useful for the manufacture of recombinant RNA and proteins and for Nanotechnology applications.…